Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2)

por Li, Yan, Li, Ling, De Peng, Yong, Song, Guang Yao, Ye, Shan Dong, Du, Li Ying, Hou, Jia Ning, Ji, Qiu He
Publicado 2019

Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post‐hoc analyses of a randomized, double‐blind, phase III study...

por Shi, Li Xin, Liu, Xiao Min, Shi, Yong Quan, Li, Quan Min, Ma, Jian Hua, Li, Yan Bing, Du, Li Ying, Wang, Feng, Chen, Lu Lu
Publicado 2019